目的评价甲真菌病临床评分指数(SCIO)指导伊曲康唑冲击和特比萘芬连续疗法治疗甲真菌病的疗效、安全性及费用疗效比。
Objective To assess the efficacy, safety and cost-effectiveness of itraconazole and terbinafine for the treatment of onychomycosis, evaluated by the scoring clinical index of onychomycosis (SCIO).
目的评价甲真菌病临床评分指数(SCIO)指导伊曲康唑冲击和特比萘芬连续疗法治疗甲真菌病的疗效、安全性及费用疗效比。
Objective To assess the efficacy, safety and cost-effectiveness of itraconazole and terbinafine for the treatment of onychomycosis, evaluated by the scoring clinical index of onychomycosis (SCIO).
应用推荐